Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hypertension, Portal"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-25 z 1140
Tytuł:
Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension.
Autorzy:
Pastrovic F; Department of Gastroenterology, Hepatology and Clinical Nutrition, Laboratory for Liver Diseases and Portal Hypertension, University Hospital Dubrava, Zagreb, Croatia.; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Novak R; Department of Proteomics, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb, Croatia.; University of Zagreb, School of Medicine, Zagreb, Croatia.; Biomedical Research Center Salata, University of Zagreb, School of Medicine, Zagreb, Croatia.
Grgurevic I; Department of Gastroenterology, Hepatology and Clinical Nutrition, Laboratory for Liver Diseases and Portal Hypertension, University Hospital Dubrava, Zagreb, Croatia.; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.; University of Zagreb, School of Medicine, Zagreb, Croatia.
Hrkac S; Department of Clinical Immunology, Allergology and Rheumatology, University Hospital Dubrava, Zagreb, Croatia.
Salai G; Department of Pulmonology, University Hospital Dubrava, Zagreb, Croatia.
Zarak M; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.; Clinical Department of Laboratory Diagnostics, University Hospital Dubrava, Zagreb, Croatia.
Grgurevic L; Department of Proteomics, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb, Croatia.; Biomedical Research Center Salata, University of Zagreb, School of Medicine, Zagreb, Croatia.; Department of Anatomy, ˝Drago Perovic˝, School of Medicine, University of Zagreb, Zagreb, Croatia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 11; Vol. 19 (4), pp. e0301416. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Portal*
Elasticity Imaging Techniques*
Humans ; Vascular Endothelial Growth Factor C ; Tenascin ; Proteomics ; Liver ; Liver Cirrhosis ; Portal Pressure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats.
Autorzy:
Asada S; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Kaji K; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Nishimura N; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Koizumi A; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Matsuda T; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Tanaka M; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Yorioka N; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Sato S; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Kitagawa K; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Namisaki T; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Akahane T; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Yoshiji H; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Mar 19; Vol. 13 (6). Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Endothelial Cells*/pathology
Hypertension, Portal*/drug therapy
Benzhydryl Compounds*
Glucosides*
Rats ; Male ; Animals ; Rats, Inbred F344 ; Liver Cirrhosis/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
Autorzy:
Kinami T; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Uchikawa S; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Kawaoka T; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Yamasaki S; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Kosaka M; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Johira Y; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Yano S; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Amioka K; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Naruto K; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Yamaoka K; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Fujii Y; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Fujino H; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Nakahara T; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ono A; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Murakami E; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Okamoto W; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Yamauchi M; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Miki D; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Tsuge M; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Oka S; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7025.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*
Liver Neoplasms*
Hypertension, Portal*
Varicose Veins*
Antibodies, Monoclonal, Humanized*
Humans ; Bevacizumab
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.
Autorzy:
Kotani K; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Kawada N; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2024 Jan 15; Vol. 18 (1), pp. 27-39. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hepatitis C, Chronic*/drug therapy
Hypertension, Portal*/complications
Hypertension, Portal*/drug therapy
Humans ; Antiviral Agents/therapeutic use ; Endothelial Cells/physiology ; Liver/blood supply ; Liver Cirrhosis/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis.
Autorzy:
Xiang ZQ; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Wu YC; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Qu XL; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Luo DJ; Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Liang H; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Ameer S; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Long ZT; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Dai XM; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. .
Zhu Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. .; Department of Education and Training, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Jan 03; Vol. 22 (1), pp. 3. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/complications
Liver Neoplasms*/surgery
Hypertension, Portal*/complications
Hypertension, Portal*/surgery
Laparoscopy*/adverse effects
Humans ; Hepatectomy/adverse effects ; Treatment Outcome ; Length of Stay ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol.
Autorzy:
Nasr P; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Wallenberg Centre for Molecular Medicine, Linköping University, Linköping, Sweden.
Forsgren M; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.; AMRA Medical AB, Linköping, Sweden.
Balkhed W; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Jönsson C; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Dahlström N; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.
Simonsson C; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden.
Cai S; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden.
Cederborg A; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Henriksson M; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Stjernman H; Department of Internal Medicine, Ryhov Hospital Jönköping, Jönköping, Sweden.
Rejler M; Department of Medicine, Höglandssjukhuset Eksjö, Region Jönköping County Council, Jönköping, Sweden.; The Jönköping Academy for Improvement of Health and Welfare, Hälsohögskolan, Jönköping University, Jönköping, Sweden.
Sjögren D; Department of Medicine, Höglandssjukhuset Eksjö, Region Jönköping County Council, Jönköping, Sweden.
Cedersund G; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden.; School of Medical Sciences and Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Bartholomä W; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.
Rydén I; Department of Research, Region Kalmar County, Kalmar, Sweden.; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Lundberg P; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.
Kechagias S; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Leinhard OD; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.; AMRA Medical AB, Linköping, Sweden.
Ekstedt M; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden. .; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Dec 21; Vol. 23 (1), pp. 454. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/epidemiology
End Stage Liver Disease*
Hypertension, Portal*/complications
Hypertension, Portal*/pathology
Liver Neoplasms*/epidemiology
Sarcopenia*/diagnostic imaging
Sarcopenia*/etiology
Humans ; Biological Specimen Banks ; Biomarkers ; Cachexia/etiology ; Cachexia/complications ; Liver Cirrhosis/diagnosis ; Prospective Studies ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study.
Autorzy:
Wang X; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.; Hygienic Company of 65529 Troops of PLA, Liaoyang, Liaoning, China.
Sun X; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Lei Y; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Pei J; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Ma K; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Feng K; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Lau WY; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.; Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Xia F; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Journal of investigative surgery : the official journal of the Academy of Surgical Research [J Invest Surg] 2023 Dec; Vol. 36 (1), pp. 1-7.
Typ publikacji:
Journal Article
MeSH Terms:
Hypersplenism*/etiology
Hypersplenism*/surgery
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/surgery
Liver Transplantation*/adverse effects
Liver Neoplasms*/complications
Liver Neoplasms*/surgery
Hypertension, Portal*/complications
Hypertension, Portal*/surgery
Radiofrequency Ablation*/adverse effects
Humans ; Splenectomy/adverse effects ; Retrospective Studies ; Treatment Outcome ; Liver Cirrhosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Unique Case of Caroli Disease in Kenya's Medical Landscape.
Autorzy:
Lengoiboni T; Department of Internal Medicine, Moi University School of Medicine, Eldoret, Kenya.
Kailani L; Department Internal Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Bikoro MK; Department Internal Medicine, Chuka County Referral Hospital, Meru, Kenya.
Mudeheri MM; Department of Internal Medicine, Moi Teaching and Referral Hospital, Eldoret, Kenya.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Jan 12; Vol. 25, pp. e942019. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Caroli Disease*/complications
Caroli Disease*/diagnosis
Caroli Disease*/pathology
Cholangitis*/diagnosis
Hypertension, Portal*/complications
Jaundice*
Adolescent ; Humans ; Male ; Abdominal Pain ; Kenya
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
Autorzy:
Yardeni D; Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, P.O.B. 151, 84101, Beersheba, Israel. .
Shiloh A; Clinical Research Center, Soroka University Medical Center, Beersheba, Israel.
Lipnizkiy I; Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, P.O.B. 151, 84101, Beersheba, Israel.
Nevo-Shor A; Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, P.O.B. 151, 84101, Beersheba, Israel.
Abufreha N; Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, P.O.B. 151, 84101, Beersheba, Israel.
Munteanu D; Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, P.O.B. 151, 84101, Beersheba, Israel.
Novack V; Clinical Research Center, Soroka University Medical Center, Beersheba, Israel.
Etzion O; Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, P.O.B. 151, 84101, Beersheba, Israel.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 13; Vol. 13 (1), pp. 22113. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
End Stage Liver Disease*/complications
Hypertension, Portal*/complications
Esophageal and Gastric Varices*/complications
Fatty Liver*/complications
Liver Diseases, Alcoholic*/complications
Humans ; Retrospective Studies ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis.
Autorzy:
Kaps L; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.; Cirrhosis Centre Mainz (CCM), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Medina-Montano C; Department of Dermatology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Bros M; Department of Dermatology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Grabbe S; Department of Dermatology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Gairing SJ; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.; Cirrhosis Centre Mainz (CCM), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Schleicher EM; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.; Cirrhosis Centre Mainz (CCM), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Gehring S; Department of Paediatrics, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Schattenberg JM; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.; Metabolic Liver Research Program, Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Galle PR; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Wörns MA; Department of Gastroenterology, Hematology, Oncology and Endocrinology, Klinikum Dortmund, Dortmund, Germany.
Nagel M; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.; Department of Gastroenterology, Hematology, Oncology and Endocrinology, Klinikum Dortmund, Dortmund, Germany.
Labenz C; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.; Cirrhosis Centre Mainz (CCM), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Pokaż więcej
Źródło:
Mediators of inflammation [Mediators Inflamm] 2023 Nov 29; Vol. 2023, pp. 9930902. Date of Electronic Publication: 2023 Nov 29 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Interleukin-10*
Hypertension, Portal*
Humans ; Interleukin-18 ; Interleukin-17 ; Interleukin-33 ; Cytokines ; Tumor Necrosis Factor-alpha ; Jugular Veins ; Interleukin-6 ; Interleukin-8 ; Liver Cirrhosis ; Interleukin-23
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension.
Autorzy:
Liu H; Liver Unit, University of Calgary Cumming School of Medicine, Calgary, AB T2N 4N1, Canada.
Nguyen HH; Liver Unit, University of Calgary Cumming School of Medicine, Calgary, AB T2N 4N1, Canada.
Hwang SY; Liver Unit, University of Calgary Cumming School of Medicine, Calgary, AB T2N 4N1, Canada.
Lee SS; Liver Unit, University of Calgary Cumming School of Medicine, Calgary, AB T2N 4N1, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 27; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Esophageal and Gastric Varices*/complications
Hepatorenal Syndrome*/complications
Endotoxemia*/complications
Hypertension, Portal*/complications
Cardiomyopathies*/complications
Cardiovascular Abnormalities*/complications
Humans ; Reactive Oxygen Species/pharmacology ; Gastrointestinal Hemorrhage ; Liver Cirrhosis/therapy ; Oxidative Stress ; Inflammation/complications ; Endotoxins/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risks and benefits of TIPS in HCC and other liver malignancies: a literature review.
Autorzy:
Fichtl A; Department of Gastroenterology and Hepatology Internal Medicine I, University Ulm, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm, 89081, Germany. .
Seufferlein T; Department of Gastroenterology and Hepatology Internal Medicine I, University Ulm, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm, 89081, Germany.
Zizer E; Department of Gastroenterology and Hepatology Internal Medicine I, University Ulm, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm, 89081, Germany.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Nov 20; Vol. 23 (1), pp. 403. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/complications
Liver Neoplasms*/surgery
Esophageal and Gastric Varices*/complications
Portasystemic Shunt, Transjugular Intrahepatic*/adverse effects
Portasystemic Shunt, Transjugular Intrahepatic*/methods
Hypertension, Portal*/complications
Humans ; Treatment Outcome ; Gastrointestinal Hemorrhage/therapy ; Gastrointestinal Hemorrhage/complications ; Liver Cirrhosis/complications ; Risk Assessment ; Ascites/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients.
Autorzy:
Liao Y; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China.; Department of Hepatobiliary Interventional Therapy, Beijing Tsinghua Changgung Hospital, Beijing, China.; School of Clinical Medicine, Tsinghua University, Beijing, 100038, People's Republic of China.; Department of Hepatobiliary Surgery, Xingtai People's Hospital of Hebei Medical University, Xingtai, 054001, Hebei, People's Republic of China.
Zhang L; Department of Hepatobiliary Interventional Therapy, Beijing Tsinghua Changgung Hospital, Beijing, China.; School of Clinical Medicine, Tsinghua University, Beijing, 100038, People's Republic of China.
Wang JT; Department of Hepatobiliary Surgery, Xingtai People's Hospital of Hebei Medical University, Xingtai, 054001, Hebei, People's Republic of China.
Yue ZD; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China.
Fan ZH; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China.
Wu YF; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China.
Zhang Y; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China.
Dong CB; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China.
Wang XQ; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China.
Cui T; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China.
Meng MM; Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.
Bao L; Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.
Chen SB; Department of Hepatobiliary Surgery, Xingtai People's Hospital of Hebei Medical University, Xingtai, 054001, Hebei, People's Republic of China.
Liu FQ; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China. .
Wang L; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing, 100038, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 14; Vol. 13 (1), pp. 15244. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatic Encephalopathy*/etiology
Portasystemic Shunt, Transjugular Intrahepatic*/adverse effects
Hypertension, Portal*/etiology
Hypertension, Portal*/surgery
Humans ; Ammonia ; Creatinine ; Nomograms ; Retrospective Studies ; Indocyanine Green
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension.
Autorzy:
Mukhiya G; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Han X; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China .
Jiao D; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Bi Y; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Pokhrel G; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Liu Z; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Li Z; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
He Y; Department of Interventional Radiology, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe state) Mungzi, Yunnan, China.
Pokaż więcej
Źródło:
Clinical medicine & research [Clin Med Res] 2023 Sep; Vol. 21 (3), pp. 144-154.
Typ publikacji:
Journal Article
MeSH Terms:
Portasystemic Shunt, Transjugular Intrahepatic*/adverse effects
Portasystemic Shunt, Transjugular Intrahepatic*/methods
Esophageal and Gastric Varices*/complications
Esophageal and Gastric Varices*/surgery
Hepatic Encephalopathy*/therapy
Hepatic Encephalopathy*/complications
Hepatic Encephalopathy*/epidemiology
Hypertension, Portal*/complications
Hypertension, Portal*/therapy
Humans ; Coronary Vessels/surgery ; Gastrointestinal Hemorrhage/therapy ; Gastrointestinal Hemorrhage/prevention & control ; Liver Cirrhosis/complications ; Liver Cirrhosis/therapy ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Transjugular liver biopsy: enlarge the indications for liver biopsy with reliable diagnostic quality.
Autorzy:
Chen MY; Department of liver diseases, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, No.1 Zhongfu Road, Gulou District, Nanjing, 210003, China.
Yang AY; Department of liver diseases, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, No.1 Zhongfu Road, Gulou District, Nanjing, 210003, China.
Hu YF; Department of liver diseases, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, No.1 Zhongfu Road, Gulou District, Nanjing, 210003, China.
Yang YF; Department of liver diseases, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, No.1 Zhongfu Road, Gulou District, Nanjing, 210003, China. .
Xiong QF; Department of liver diseases, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, No.1 Zhongfu Road, Gulou District, Nanjing, 210003, China.
Zhong YD; Department of liver diseases, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, No.1 Zhongfu Road, Gulou District, Nanjing, 210003, China.
Liu DX; Department of pathology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, No.1 Zhongfu Road, Gulou District, Nanjing, 210003, China.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Aug 14; Vol. 23 (1), pp. 282. Date of Electronic Publication: 2023 Aug 14.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Diseases*/pathology
Hypertension, Portal*/etiology
Hypertension, Portal*/pathology
Humans ; Jugular Veins/pathology ; Liver/pathology ; Biopsy/adverse effects ; Biopsy/methods ; Abdominal Pain/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.
Autorzy:
Cadranel JD; Hepatogastroenterology and Nutrition Department GHPSO Boulevard Laennec, 60100, Creil, France. .
Ollivier-Hourmand I; Hepatogastroenterology department, CHU Caen, Caen, France.
Cadranel J; Pneumology Department, Tenon, Paris, France.
Thevenot T; Hepatology and Intensive Care Unit, Besançon, France.
Zougmore H; Hepatogastroenterology and Nutrition Department GHPSO Boulevard Laennec, 60100, Creil, France.
Nguyen-Khac E; Hepatogastroenterology department, Amiens, France.
Bureau C; Hepatogastroenterology department, Toulouse, France.
Allaire M; Hepatogastroenterology Department, La Pitié Salpétrière, Paris, France.
Nousbaum JB; Hepatogastroenterology department, Brest, France.
Loustaud-Ratti V; Hepatogastroenterology department, Limoges, France.
Causse X; Hepatogastroenterology department, Orléans, France.
Sogni P; Hepatology Department, Cochin, Paris, France.
Hanslik B; Gastroenterology Practice, Montpellier, France.
Bourliere M; Hepatogastroenterology department, Saint-Joseph, Marseille, France.
Peron JM; Hepatogastroenterology department, Toulouse, France.
Ganne-Carrie N; Hepatogastroenterology department, Bobigny, France.
Dao T; Hepatogastroenterology department, CHU Caen, Caen, France.
Thabut D; Hepatogastroenterology Department, La Pitié Salpétrière, Paris, France.
Maitre B; Pneumology department, CHIC Créteil, Créteil, France.
Debzi N; Hepatology Department CHU Mustapha, Alger, Algérie, Algeria.
Smadhi R; Hepatogastroenterology and Nutrition Department GHPSO Boulevard Laennec, 60100, Creil, France.; Hepatology Department CHU Mustapha, Alger, Algérie, Algeria.
Sombie R; Gastroenterology Department, CHU Yalgado Ouedraogo Ouagadougou, Ouagadougou, Burkina Faso.
Kpossou R; Hepatogastroenterology Deparment, National Hospital and University Center Hubert Koutoukou Maga, Cotonou, Benin.
Nouel O; Hepatogastroenterology Department, St Brieuc, France.
Bissonnette J; Department of Hepatology and Liver Transplantation, University of Montreal Hospital, Montreal, Canada.
Ruiz I; Department of Hepatology and Liver Transplantation, University of Montreal Hospital, Montreal, Canada.
Medmoun M; Hepatogastroenterology and Nutrition Department GHPSO Boulevard Laennec, 60100, Creil, France.
Dastis SN; Hepatogastroenterology Department, Brussels, Belgium.
Deltenre P; Hepatogastroenterology Department, Brussels, Belgium.
Artru F; Hepatogastroenterology Department, Lausanne, Suisse, Switzerland.
Raherison C; Pneumology department, Bordeaux, France.
Elkrief L; Hepatogastroenterology department, Tours, France.
Lemagoarou T; DIM, GHPSO, Creil, France.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Sep 12; Vol. 23 (1), pp. 305. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Hydrothorax*/diagnosis
Hydrothorax*/etiology
Hydrothorax*/therapy
Gastroenterologists*
Pleural Effusion*/diagnosis
Pleural Effusion*/etiology
Pleural Effusion*/therapy
Hypertension, Portal*
Humans ; Pulmonologists
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis.
Autorzy:
Giuli L; Hepatology Unit, CEMAD Centro Malattie Dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.
Pallozzi M; Hepatology Unit, CEMAD Centro Malattie Dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.
Venturini G; Hepatology Unit, CEMAD Centro Malattie Dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.
Gasbarrini A; Hepatology Unit, CEMAD Centro Malattie Dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Ponziani FR; Hepatology Unit, CEMAD Centro Malattie Dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.
Santopaolo F; Hepatology Unit, CEMAD Centro Malattie Dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 13; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Thrombosis*/etiology
Vascular Diseases*
Hypertension, Portal*
Humans ; Animals ; Liver Cirrhosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension.
Autorzy:
Jose A; Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA. .
Elwing JM; Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Kawut SM; Department of Medicine, Perelman School at the University of Pennsylvania, Philadelphia, PA, USA.
Pauciulo MW; Division of Human Genetics, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Sherman KE; Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Nichols WC; Division of Human Genetics, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Fallon MB; Department of Medicine, University of Arizona, Phoenix, AZ, USA.
McCormack FX; Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2023 Aug 09; Vol. 6 (1), pp. 826. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Liver Transplantation*
Hypertension, Pulmonary*/genetics
Hypertension, Portal*/genetics
Pulmonary Arterial Hypertension*/genetics
Humans ; Arginine ; Estrogens ; Bone Morphogenetic Protein Receptors, Type II/genetics ; Growth Differentiation Factor 15
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients.
Autorzy:
Fernández-Alvarez P; Department of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Guerra-Veloz MF; Department of Gastroenterology and Hepatology, King's College Hospital, London SE5 9RS, UK.
Vilches-Arenas A; Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Seville, 41009 Seville, Spain.
Cordero-Ruíz P; Department of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Bellido-Muñoz F; Department of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Caunedo-Alvarez A; Department of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Carmona-Soria I; Department of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 May 26; Vol. 15 (6). Date of Electronic Publication: 2023 May 26.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*
Liver Neoplasms*
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/drug therapy
Hypertension, Portal*/diagnosis
Hypertension, Portal*/complications
Hypertension, Portal*/drug therapy
Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Retrospective Studies ; Liver Cirrhosis/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Innovative angiography: a new approach to discover more hepatic vein collaterals in patients with cirrhotic portal hypertension.
Autorzy:
Liu B; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China.
Yue Z; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China.
Cui T; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China.
Zhao H; Department of Interventional Therapy, Beijing Tongren Hospital, Capital Medical University, Beijing, 100005, China.
Wang L; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China.
Fan Z; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China.
Wu Y; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China.
Meng M; Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Zhang K; Department of General Surgery, Beijing Ditan Hospital, Capital Medical University, Beijing, 100102, China.
Jiang L; Department of General Surgery, Beijing Ditan Hospital, Capital Medical University, Beijing, 100102, China.
Ding H; Department of Gastroenterology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China.
Zhang Y; Department of Gastroenterology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China.
Liu F; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 May 10; Vol. 23 (1), pp. 144. Date of Electronic Publication: 2023 May 10.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatic Veins*/diagnostic imaging
Hypertension, Portal*/diagnostic imaging
Hypertension, Portal*/etiology
Humans ; Liver Cirrhosis, Alcoholic ; Liver Cirrhosis/complications ; Liver Cirrhosis/diagnostic imaging ; Angiography ; Portal Vein/diagnostic imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Close Relationship between Systemic Arterial and Portal Venous Pressure in an Animal Model with Healthy Liver.
Autorzy:
Lazaro A; Institute of Exercise and Occupational Medicine, Faculty of Medicine, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Stoll P; Narkose Suedbaden, 79110 Freiburg, Germany.
von Elverfeldt D; Department of Diagnostic and Interventional Radiology, Division of Medical Physics, Faculty of Medicine, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Kreisel W; Department of Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, Faculty of Medicine, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Deibert P; Institute of Exercise and Occupational Medicine, Faculty of Medicine, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 09; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:
Journal Article
MeSH Terms:
Portal Pressure*
Hypertension, Portal*/drug therapy
Rats ; Animals ; Sildenafil Citrate/pharmacology ; Hemodynamics ; Models, Animal ; Norepinephrine/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Partial splenic embolization as a rescue and emergency treatment for portal hypertension and gastroesophageal variceal hemorrhage.
Autorzy:
Pavel V; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Scharf G; Department of Radiology, University Hospital Regensburg, Regensburg, Germany.
Mester P; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Krauss LU; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Gülow K; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Mehrl A; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Müller M; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Schmid S; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 May 24; Vol. 23 (1), pp. 180. Date of Electronic Publication: 2023 May 24.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal and Gastric Varices*/complications
Esophageal and Gastric Varices*/therapy
Embolization, Therapeutic*
Hypertension, Portal*/complications
Humans ; Gastrointestinal Hemorrhage/etiology ; Gastrointestinal Hemorrhage/therapy ; Emergency Treatment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection.
Autorzy:
Kablawi D; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Québec, Canada.
Alhinai A; Division of Experimental Medicine, McGill University, Montreal, Québec, Canada.
Wong P; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Québec, Canada.
Deschenes M; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Québec, Canada.
Sebastiani G; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montreal, Québec, Canada.
Benmassaoud A; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Québec, Canada.
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2023 Mar; Vol. 24 (3), pp. 366-371. Date of Electronic Publication: 2022 Aug 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
Hypertension, Portal*/complications
Hypertension, Portal*/diagnosis
Hypertension, Portal*/pathology
Elasticity Imaging Techniques*/methods
Male ; Humans ; Middle Aged ; Liver Cirrhosis/complications ; Splenomegaly/complications ; Splenomegaly/pathology ; Prospective Studies ; Liver/diagnostic imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis.
Autorzy:
Gillespie SL; Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, UK.
Hanrahan TP; Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, UK.; Department of Gastroenterology and Hepatology, Austin Health, Melbourne, Australia.
Rockey DC; Digestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Majumdar A; Department of Gastroenterology and Hepatology, Austin Health, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.
Hayes PC; Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, UK.; College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 454-463. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Esophageal and Gastric Varices*/drug therapy
Esophageal and Gastric Varices*/prevention & control
Esophageal and Gastric Varices*/complications
Hypertension, Portal*/complications
Hypertension, Portal*/drug therapy
Varicose Veins*/complications
Humans ; Carvedilol/therapeutic use ; Ascites/etiology ; Ascites/complications ; Gastrointestinal Hemorrhage/drug therapy ; Gastrointestinal Hemorrhage/etiology ; Gastrointestinal Hemorrhage/prevention & control ; Adrenergic beta-Antagonists/therapeutic use ; Liver Cirrhosis/complications ; Liver Cirrhosis/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension.
Autorzy:
Vandenberk B; Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Altieri MH; Division of Gastroenterology, Hepatology and Nutrition, CHU Caen, Caen, France.
Liu H; Liver Unit, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Raj SR; Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Autonomic Dysfunction Center, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Lee SS; Liver Unit, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (3), pp. 290-303. Date of Electronic Publication: 2022 Dec 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/epidemiology
Stroke*/drug therapy
Stroke*/epidemiology
Stroke*/etiology
Hypertension, Portal*/complications
Hypertension, Portal*/diagnosis
Humans ; Hemorrhage/epidemiology ; Anticoagulants/therapeutic use ; Liver Cirrhosis/complications ; Liver Cirrhosis/diagnosis ; Administration, Oral ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-25 z 1140

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies